The respiratory care landscape is undergoing a massive shift as new medical breakthroughs redefine how we manage chronic lung conditions. With the Asthma Therapeutics Market Share being split between traditional inhalers and high-tech biologics, the industry is seeing a surge in patient-centric solutions. This evolution is not just about relieving symptoms but about fundamentally changing the...